Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression

The kinetics of retroviral DNA and RNA synthesis are parameters vital to understanding viral growth, especially for human immunodeficiency virus (HIV), which encodes several of its own regulatory genes. We have established a single-cycle growth condition for HIV in H9 cells, a human CD4+ lymphocyte line. The full-length viral linear DNA is first detectable by 4 h postinfection. During a one-step growth of HIV, amounts of viral DNA gradually increase until 8 to 12 h postinfection and then decrease. The copy number of unintegrated viral DNA is not extraordinarily high even at its peak. Most strikingly, there is a temporal program of RNA accumulation: the earliest RNA is greatly enriched in the 2-kilobase subgenomic mRNA species, while the level of 9.2-kilobase RNA which is both genomic RNA and mRNA remains low until after 24 h of infection. Virus production begins at about 24 h postinfection. Thus, viral DNA synthesis is as rapid as for other retroviruses, but viral RNA synthesis involves temporal alteration in the species that accumulate, presumably as a consequence of viral regulatory genes.

[1]  A. Haase,et al.  Slow virus visna: reproduction in vitro of virus from extrachromosomal DNA. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[3]  M. Feinberg,et al.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA , 1986, Cell.

[4]  R. Gallo,et al.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.

[5]  S. Josephs,et al.  Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Temin Mechanisms of cell killing/cytopathic effects by nonhuman retroviruses. , 1988, Reviews of infectious diseases.

[7]  H. Temin,et al.  Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA , 1979, Journal of virology.

[8]  R. Schooley,et al.  HTLV-III in the semen and blood of a healthy homosexual man. , 1984, Science.

[9]  M. Malim,et al.  Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes , 1988, Nature.

[10]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[11]  F. Wong-Staal,et al.  Site-directed mutagenesis of two trans-regulatory genes (tat-III,trs) of HIV-1. , 1988, Science.

[12]  H. Temin,et al.  Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus , 1980, Journal of virology.

[13]  S. Le,et al.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA , 1989, Nature.

[14]  H. Varmus,et al.  Virus-specific DNA in the cytoplasm of avian sarcoma virus-infected cells is a precursor to covalently closed circular viral DNA in the nucleus , 1978, Journal of virology.

[15]  V. Barban,et al.  Transcription of visna virus during its lytic cycle: evidence for a sequential early and late gene expression. , 1987, Virology.

[16]  L. Lasky,et al.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus , 1985, Nature.

[17]  L. Wysocki,et al.  "Panning" for lymphocytes: a method for cell selection. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[18]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[19]  S. Arya,et al.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.

[20]  J. Groopman,et al.  CD4+ lymphocyte function with early human immunodeficiency virus infection. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. M. Hendry,et al.  Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus. , 1988, The Journal of infectious diseases.

[22]  I. Weissman,et al.  Infection of the SCID-hu mouse by HIV-1. , 1988, Science.

[23]  B. Franza,et al.  The Control of Human Retrovirus Gene Expression , 1988 .

[24]  E. Southern Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[25]  M. Somasundaran,et al.  Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection. , 1988, Science.

[26]  G. Shaw,et al.  Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. , 1984, Science.

[27]  Eric C. Holland,et al.  HIV-1 tat trans-activation requires the loop sequence within tar , 1988, Nature.

[28]  I. Weissman,et al.  Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus , 1988, Cell.

[29]  B. Hirt Selective extraction of polyoma DNA from infected mouse cell cultures. , 1967, Journal of molecular biology.

[30]  G. Quérat,et al.  Genetic structure and function of an early transcript of visna virus , 1988, Journal of virology.